Skip to main content
Austar Lifesciences Limited logo

Austar Lifesciences Limited — Investor Relations & Filings

Ticker · 6118 ISIN · KYG0632L1023 HKEX Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country HK Hong Kong
Listing HKEX 6118

About Austar Lifesciences Limited

http://www.austar.com.hk

Austar Lifesciences Limited provides integrated engineering solutions, equipment, services, and consumables to pharmaceutical manufacturers and research institutes in the life sciences sector. The company delivers turnkey solutions focused on quality, compliance, and operational excellence, utilizing extensive expertise in process technology and regulatory practices. Core offerings include specialized systems for bioprocessing, clean utilities, pharmaceutical preparation, aseptic freeze-drying, filling, visual inspection, clean room environments, and automation control. Products span Bioprocess Equipment, Clean Utility Equipment & Chemical Pharmaceutical Preparation Systems, and Pharmaceutical Process Contamination Control Products, ensuring comprehensive support for complex manufacturing and research needs.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Regulatory Filings Classification · 88% confidence The document is a standard Hong Kong Exchange monthly return (Form FF301) covering movements in authorized/issued share capital and public float confirmation under Chapter 19B of the Listing Rules. It is a routine compliance/regulatory submission rather than an earnings release, financial report, or specific capital raising announcement. There is no new share issuance, buyback or detailed financial data beyond share counts. This falls under general regulatory filings.
2026-06-01 English
SECOND AMENDED AND RESTATED ARTICLES OF ASSOCIATION
Governance Information Classification · 92% confidence The document is the full text of the company’s amended and restated Articles of Association, detailing its internal governance rules, share capital provisions, board procedures, meeting and voting processes, and other constitutional matters. This is a governance framework document rather than a financial report, announcement, or regulatory filing of results. It aligns with the definition of “Governance Information” (CGR).
2026-05-22 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 22 MAY 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is an announcement of poll results from an Annual General Meeting held on 22 May 2026. It lists each resolution passed, vote counts, and percentages. This fits the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filing for an equity issuer listed on the Hong Kong Stock Exchange, detailing movements in authorised and issued share capital, public float sufficiency confirmation, and other share-related information. It is a regulatory compliance report related to share capital and public float requirements under the Exchange Listing Rules. The document does not contain financial statements, earnings data, management discussion, or audit information. It is a regulatory filing specific to share capital movements and public float confirmation, which fits best under the category of Regulatory Filings (RNS) as it is a compliance report rather than a financial report or announcement of a meeting or vote.
2026-05-05 English
NOTIFICATION LETTER WITH REQUEST FORM TO NON-REGISTERED SHAREHOLDER(S)
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 24 April 2026 from Austar Lifesciences Limited to non-registered shareholders. It informs them about the publication of the 2025 Annual Report, Circular, Form of Proxy for the Annual General Meeting, and the 2025 Environmental, Social and Governance Report. The letter provides instructions on how shareholders can access these documents electronically or request printed copies. It does not contain the actual annual report, financial statements, or detailed financial data but rather announces the availability of these reports and related corporate communications. The document also includes a request form for shareholders to choose their preferred method of receiving future corporate communications. Given the content and length (11,486 characters), it is not the report itself but an announcement of the publication of reports and related materials. According to the "Menu vs Meal" rule, such a document should be classified as a Report Publication Announcement (RPA).
2026-04-23 English
NOTIFICATION LETTER WITH REPLY FORM TO REGISTERED SHAREHOLDERS
Report Publication Announcement Classification · 87% confidence The document is a notification letter to registered shareholders informing them that the 2025 Annual Report, circular, proxy form and ESG report have been published and are available online. It does not contain the actual financial statements or report content, but merely announces their publication and distribution options. Under the “menu vs meal” rule, this is a Report Publication Announcement (RPA), not the report itself.
2026-04-23 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.